| abstract |
METHODS FOR TREATING HCV nABSTRACT nThe present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment nis over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the treatment ncomprises administering at least two direct acting antiviral agents to a subject with HCV infection, wherein nthe treatment lasts for 12 weeks and does not include administration of either interferon or ribavirin, and nsaid at least two direct acting antiviral agents comprise (a) Compound 1 or a pharmaceutically acceptable nsalt thereof and (b) Compound 2 or a pharmaceutically acceptable salt thereof. n1 |